Nephrotic Syndrome
📧 Sign up to get email alerts when something new happens for Nephrotic Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-10-20FDA Approved: BUMETANIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for bumetanide from Sandoz Inc.
-
FDA approval · 2014-08-26FDA Approved: FUROSEMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' generic furosemide (ANDA 203428) for edema-related indications and hypertension, enabling a generic v…
-
CLINICAL_TRIALS research · 2014-08-15Clinical Trial Update: Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse [Phase 4]
Phase 4 clinical trial evaluating low-dose corticosteroids for relapse of nephrotic syndrome, sponsored by Rabin Medical Center; current sta…
-
CLINICAL_TRIALS research · 2014-07-15Clinical Trial Update: Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic Syndrome
A completed clinical trial evaluating the educational experiences of patients newly diagnosed with nephrotic syndrome.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) [Phase 4]
Phase 4 clinical trial update evaluating ACTH Gel (ACTHAR) for treatment-resistant nephrotic syndrome; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-04-23FDA Approved: SPIRONOLACTONE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original ANDA for spironolactone, authorizing a generic version manufactured by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2014-03-06FDA Approved: SPIRONOLACTONE — Original Application (NorthStar Rx LLC)
The FDA approved NorthStar Rx LLC's Original Application for spironolactone (generic spironolactone).
-
FDA approval · 2014-01-27FDA Approved: FUROSEMIDE — Original Application (Civica, Inc.)
FDA approves Civica, Inc.’s original application for furosemide (generic diuretic).
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
Clinical trial investigating cardiomyopathy in steroid-resistant nephrotic syndrome associated with focal segmental glomerulosclerosis has b…
-
FDA approval · 2013-06-12FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Aldactone (spironolactone) from Pfizer. The approval updates the drug’s labeling.
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) [Phase 4]
Phase 4 clinical trial evaluating adrenocorticotropic hormone (ACTH) for nephrotic-range proteinuria in patients with diabetic nephropathy; …
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) [Phase 3]
Phase 3 clinical trial update for rituximab in multirelapsing minimal change disease or focal segmental glomerulosclerosis has completed.
-
FDA approval · 2013-01-07FDA Approved: TORSEMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' torsemide supplemental application (ANDA 079234), resulting in an approved updated torsemide product un…
-
FDA approval · 2012-12-12FDA Approved: TORSEMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for torsemide from Teva Pharmaceuticals USA, Inc., updating or expanding the product's labeling.
-
FDA approval · 2012-11-30FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for furosemide from Ipca Laboratories Limited, indicating approval of their generic furosemide p…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Efficacy of Pentoxifylline on Primary Nephrotic Syndrome [Phase 3]
A Phase 3 trial evaluating the efficacy of pentoxifylline in primary nephrotic syndrome has completed.
-
FDA approval · 2012-09-26FDA Approved: TORSEMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals, Inc.'s supplemental application for torsemide, authorizing a modification to the torsemide product unde…
-
FDA approval · 2012-09-26FDA Approved: TORSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for torsemide from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2012-09-18FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for torsemide from Rising Pharma Holdings, Inc., indicating regulatory approval of changes to the to…
-
FDA label_change · 2012-07-11FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide from Chartwell RX, LLC, resulting in changes to the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Pharmacokinetics of Cyclosporin in Nephrotic Syndrome
A completed pharmacokinetic study evaluating cyclosporine in patients with nephrotic syndrome.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) [Phase 2]
A Phase 2 trial evaluating pirfenidone for focal segmental glomerulosclerosis (kidney fibrosis) has completed and posted results in 2012.
-
FDA approval · 2012-05-11FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., authorizing a generic version of the diuretic. Thi…
-
FDA approval · 2012-05-10FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2012-05-09FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for furosemide from Solco Healthcare LLC, authorizing continued production and marketing of the gene…